Non-Small Cell Lung Carcinoma TNM clinical staging
Item
histologically confirmed stage iiib/iv nsclc.
boolean
C0007131 (UMLS CUI [1,1])
C3258246 (UMLS CUI [1,2])
Disease Progression Timespan | EGFR Tyrosine Kinase inhibitors
Item
investigator confirmed progression according recist 1.1 during egfr tki treatment within 28 days of the randomization
boolean
C0242656 (UMLS CUI [1,1])
C0872291 (UMLS CUI [1,2])
C1443775 (UMLS CUI [2])
EGFR Activating Mutation | EGFR G719A | EGFR G719C | EGFR G719S | EGFR Exon 19 Insertion | EGFR exon 19 deletion | EGFR L858R | EGFR L861Q | Partial response EGFR Tyrosine Kinase inhibitors
Item
activating mutation (g719a/c/s; exon 19 insertion/deletion; l858r; l861q) in the egfr gene or have had at least partial response with egfr tki lasting ≥ 6 months
boolean
C2984891 (UMLS CUI [1])
C3274209 (UMLS CUI [2])
C3274211 (UMLS CUI [3])
C3274216 (UMLS CUI [4])
C4525161 (UMLS CUI [5])
C3889117 (UMLS CUI [6])
C3274204 (UMLS CUI [7])
C3274186 (UMLS CUI [8])
C1521726 (UMLS CUI [9,1])
C1443775 (UMLS CUI [9,2])
Performance status
Item
performance status: who 0-2
boolean
C1518965 (UMLS CUI [1])
Measurable Disease
Item
measurable disease according to recist 1.1
boolean
C1513041 (UMLS CUI [1])
Compliance behavior Investigational Therapy
Item
patients must be able to comply with study treatments
boolean
C1321605 (UMLS CUI [1,1])
C0949266 (UMLS CUI [1,2])
Females & males of reproductive potential Contraceptive methods
Item
women with child-bearing potential and men with reproductive potential must be willing to practice acceptable methods of birth control during the study
boolean
C4034483 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
Neutrophil count | Platelet Count measurement | Alanine aminotransferase measurement | Secondary malignant neoplasm of liver
Item
neutrophils ≥ 1'000/μl, platelets ≥ 100'000/μl, alanine amino transferase ≤ 2.5 ×
boolean
C0200633 (UMLS CUI [1])
C0032181 (UMLS CUI [2])
C0201836 (UMLS CUI [3])
C0494165 (UMLS CUI [4])
Alkaline phosphatase measurement | Secondary malignant neoplasm of liver
Item
upper limit of normal (uln) (< 5 × uln if liver metastases), alkaline phosphatase ≤
boolean
C0201850 (UMLS CUI [1])
C0494165 (UMLS CUI [2])
Serum total bilirubin measurement | Creatinine measurement, serum
Item
2.5 × uln (< 5 × uln if liver metastases), serum bilirubin ≤ 1.5 × uln, serum creatinine ≤ 1.5 × uln.
boolean
C1278039 (UMLS CUI [1])
C0201976 (UMLS CUI [2])
Protocol Compliance
Item
patient must be able to comply with the protocol
boolean
C0525058 (UMLS CUI [1])
Disease Progression Timespan | EGFR Tyrosine Kinase inhibitors
Item
recist 1.1 defined disease progression for more than 28 days while on previous egfr tki treatment.
boolean
C0242656 (UMLS CUI [1,1])
C0872291 (UMLS CUI [1,2])
C1443775 (UMLS CUI [2])
Investigational New Drugs
Item
patient has been treated with any investigational agent for any indication within 4 weeks of study treatment.
boolean
C0013230 (UMLS CUI [1])
Hypersensitivity Erlotinib | Intolerance to Erlotinib | Hypersensitivity Gefitinib | Intolerance to Gefitinib
Item
patient has history of hypersensitivity or intolerance to erlotinib or gefitinib.
boolean
C0020517 (UMLS CUI [1,1])
C1135135 (UMLS CUI [1,2])
C1744706 (UMLS CUI [2,1])
C1135135 (UMLS CUI [2,2])
C0020517 (UMLS CUI [3,1])
C1122962 (UMLS CUI [3,2])
C1744706 (UMLS CUI [4,1])
C1122962 (UMLS CUI [4,2])
Hypersensitivity Antineoplastic Agents | Intolerance to Antineoplastic Agents
Item
patient has history of hypersensitivity or intolerance to chemotherapeutic agents used in the study.
boolean
C0020517 (UMLS CUI [1,1])
C0003392 (UMLS CUI [1,2])
C1744706 (UMLS CUI [2,1])
C0003392 (UMLS CUI [2,2])
CNS metastases Symptomatic
Item
patient with symptomatic central nervous system metastases
boolean
C0686377 (UMLS CUI [1,1])
C0231220 (UMLS CUI [1,2])
Hepatitis B | Hepatitis C | HIV Infection
Item
patient has known active hepatitis b or c, or hiv infection
boolean
C0019163 (UMLS CUI [1])
C0019196 (UMLS CUI [2])
C0019693 (UMLS CUI [3])
Pregnancy | Breast Feeding
Item
pregnant or breastfeeding.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Comorbidity Uncontrolled Limiting Protocol Compliance | Circumstances Limiting Protocol Compliance
Item
patient with uncontrolled undercurrent illness or circumstances that could limit compliance with the study
boolean
C0009488 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
C0439801 (UMLS CUI [1,3])
C0525058 (UMLS CUI [1,4])
C0680082 (UMLS CUI [2,1])
C0439801 (UMLS CUI [2,2])
C0525058 (UMLS CUI [2,3])